Pfizer is so sure that this pill, which will need to be taken twice day, will be approved by the end of the year (duh, the FDA is in their back pocket) that they are combining the Phase 2 and Phase 3 trials and are running them concurrently. And they’ve already started production.
They say that the new pill is: an “investigational orally administered protease inhibitor antiviral therapy designed specifically to combat COVID–19 – in non–hospitalized, symptomatic adult participants who have a confirmed diagnosis of SARS–CoV–2 infection and are not at increased risk of progressing to severe illness, which may lead to hospitalization or death.”
Guess what else is a protease inhibitor? Ivermectin.
Smart money says that the pill will contain Ivermectin, Quercetin, Vitamin D, and Zinc (maybe a little graphene oxide, just for kicks).
Pretty sure I’m on the right track because the ‘fact checkers’ are already running around trying to ‘prove’ that this hypothesis is incorrect.
Leave a Reply